Menu Search
Equities

ClouDr Group Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
H3L:MUN

ClouDr Group Ltd

Actions
  • Price (EUR)0.108
  • Today's Change0.00 / 0.00%
  • Shares traded1.00k
  • 1 Year change-45.73%
  • Beta0.1197
Data delayed at least 15 minutes, as of Feb 16 2026 07:06 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

ClouDr Group Ltd is an investment holding company primarily engaged in providing healthcare services and products. The Company provides medical supplies and Software-as-a-Service (SaaS) products to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultations and prescription issuance for patients. The Company primarily comprises two products and service portfolios. In-hospital solutions include the sales of hospital supplies, providing hospital SaaS, and providing digital market service to pharmaceutical companies. Out-of-hospital solutions include the sales of pharmacy supplies and providing pharmacy SaaS, sales of chronic condition products to individual customers, providing premium membership services and insurance brokerage services and others. The Company operates in both domestic and overseas markets.

  • Revenue in HKD (TTM)2.55bn
  • Net income in HKD-1.08bn
  • Incorporated2015
  • Employees966.00
  • Location
    ClouDr Group LtdRooms 401, 403 and 405(A)4/F, No. 998 Wenyi West Road (HaichuangHANGZHOU ChinaCHN
  • Websitehttps://www.cloudr.cn/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.